28th Jun 2013 09:00
28 June 2013
Immunodiagnostic Systems Holdings PLC
("IDS", or "Company")
2013 Annual Report & Accounts and Notice of Annual General Meeting
IDS, a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, confirms that it has published its Annual Report & Accounts for the year ended 31 March 2013. The document is being posted to shareholders today and is available from the Company's website: www.idsplc.com
IDS confirms that its 2013 Annual General Meeting will be held at 2.00pm on Friday 26 July 2013 at its registered office at 10 Didcot Way, Boldon Business Park, Boldon, Tyne & Wear NE35 9PD. The AGM Notice is also being posted with the Annual Report & Accounts to shareholders today and is available on the Company's website.
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 5190660 |
Patrik Dahlen, Chief Executive Officer | |
Chris Yates, Group Finance Director | |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Dr Vijay Barathan | |
FTI Consulting | Tel : +44 (0)207 831 3113 |
Ben Atwell | |
Simon Conway | |
Mo Noonan |
About Immunodiagnostic Systems Holdings PLC
The Group operates in the in-vitro diagnostics ("IVD") market by designing, manufacturing and selling immunoassay kits as well as its automated analyser, the IDS-iSYS System. The IDS product range is used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies.
http://www.idsplc.com
Related Shares:
IDH.L